TipRanks
Palisade Bio (PALI)
NASDAQ:PALI
US Market
Want to see PALI full AI Analyst Report?

Palisade Bio (PALI) Blogger Opinions & Sentiment

738 Followers

Blogger Sentiment

Bullish: 100.00%
Sector Average
Bullish
PALI Blogger sentiment is based on 6 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
50% SeekingAlpha
33% Investing
17% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Insider Buying: Robert Baltera Acquires 45,000 Shares of Palisade Bio Inc (PALI)
GuruFocus
Palisade Bio: Undervalued Biotech With Blockbuster Potential, Initiating With A Speculative Buy Rating
SeekingAlpha
Palisade Bio: Gut Prodrug For IBD With Catalysts
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of PALI?
Seeking Alpha’s Max Arnoldi has a Bullish Sentiment.
    What do Motley Fool contributors think of PALI?
    Currently there's no blogger sentiment for PALI.
    What Is PALI’s Blogger Sentiment?
    PALI’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for PALI?
      The most recent blogger prediction for PALI was made by NASDAQ:PALI, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          HCAHCA Healthcare
          ABTAbbott Laboratories
          ARGXArgenx Se
          PRNAFAlterity Therapeutics
          VRTXVertex Pharmaceuticals